This podcast was planned in collaboration with the American College of Clinical Pharmacy (ACCP) Ambulatory Care PRN. The glucagon-like peptide-1 (GLP-1) receptors agonists have documented benefits in an expanding array of patient populations are not longer simply &quot;diabetes&quot; and &quot;obesity&quot; medications.<br>Expert Panelists: Lauren Cunningham, PharmD, BCACP, CDCES and Kylee Funk, PharmD, BCPS

The Expanding Indication Map for GLP-1 Receptor Agonists

iForumRx.org

Hello, everybody. Welcome to the iForumRx.org podcast. This is Stuart Haynes, Editor-in-Chief of iForumRx.org. iFormRx is brought to you by the American College of Clinical Pharmacy. And if you're not already a member of ACCP, consider joining today. And you may have noticed that the intro music is a bit different than our usual tune. And that's because this podcast episode has been produced in

collaboration with the ACCP Ambulatory Care Practice and Research Network, or more commonly called the AmCare PRN. The topic for this episode was prompted by a needs assessment survey conducted by the PRN. Members indicated they wanted to learn more about the evolving role and the evidence

supporting glucagon-like peptide-1 or GLP-1 receptor agonists for indications beyond diabetes and weight loss. And if you're like me, it's been challenging to keep up with each of the agents' growing list of indications and potential uses. So I'm delighted to welcome our panelists today, Dr. Lauren Cunningham

and Dr. Kylie Funk, who will share with us their insights on who, what, and how they're using GLP-1 receptor agonists in their practice. Dr. Cunningham is on faculty at the University of Illinois Chicago Retsky College of Pharmacy, where she teaches content on obesity and cardiovascular risk reduction. In addition, she is a clinical pharmacy specialist in ambulatory care and practices at the

family medicine clinic and Maxwell at the University of Illinois Hospital and Health Sciences System, where she's also the assistant residency program director for their PGY-2 ambulatory care residency program. And our second guest today is Dr. Funk. She's on faculty at the University of Minnesota College of Pharmacy and provides comprehensive medication management services to patients in the

The Expanding Indication Map for GLP-1 Receptor Agonists

Read the full transcript

The candid version is on a podcast,
not the earnings call.

The Expanding Indication Map for GLP-1 Receptor Agonists

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.